West Virginia 2024 Regular Session

West Virginia House Bill HB4892

Introduced
1/18/24  
Refer
1/18/24  

Caption

Relating to the distribution of drugs to safety net providers and contract pharmacies

Impact

The proposed law will amend existing statutes related to drug distribution, specifically emphasizing compliance with federal regulations regarding 340B entities. This change is designed to ensure that state laws align closely with federal guidelines, thereby preventing potential conflicts and confusion. Moreover, the bill introduces penalties for violations, enhancing the accountability of drug manufacturers and distributors in their interactions with safety net providers.

Summary

House Bill 4892 focuses on regulating the distribution of 340B drugs to safety net providers and contract pharmacies in West Virginia. The bill aims to provide a framework that prevents manufacturers and wholesale drug distributors from denying or restricting the delivery of these drugs to authorized entities. By establishing clear definitions and requirements for the distribution process, HB4892 seeks to enhance access to essential medications for underserved populations.

Sentiment

Initial sentiment around HB4892 appears to be cautiously optimistic among its supporters, who argue that it strengthens support for safety net providers that play a critical role in healthcare access. However, there are concerns from some stakeholders about the regulatory burden it may impose on manufacturers and wholesalers, which could lead to pushback from the pharmaceutical industry. Overall, the sentiment could be characterized as supportive among healthcare advocates with an undercurrent of concern from industry players.

Contention

Notable points of contention surrounding HB4892 include the potential for added regulation affecting the pharmaceutical industry and concerns over the feasibility of ensuring compliance from all parties involved in the distribution chain. Critics may argue that while the bill aims to benefit safety net providers, it could inadvertently create barriers or complications in drug distribution. The introduction of penalties for non-compliance might also lead to fears of punitive measures that could be seen as overly harsh or financially burdensome.

Companion Bills

WV SB325

Similar To Relating to distribution of drugs to safety net providers and contract pharmacies

Previously Filed As

WV SB154

Prohibit pharmaceutical manufacturers from interfering in contracts between 340B entities and pharmacies and to provide a penalty therefor.

WV HB3489

PHARMACISTS-CONTRACEPTIVES

WV H785

Protecting 340B contract pharmacies

WV AB50

Pharmacists: furnishing contraceptives.

WV SB1279

Relating To Pharmacists.

WV SB1279

Relating To Pharmacists.

WV SB1354

Relating to the minimum reimbursement amount for prescription drugs and devices to health benefit plan network pharmacists and pharmacies.

WV HB2978

Relating to the minimum reimbursement amount for prescription drugs and devices to health benefit plan network pharmacists and pharmacies.

WV HB2965

covered entities; 340B drugs; distribution

WV HB561

Relating To Pharmacists.

Similar Bills

No similar bills found.